PTEN and breast cancer: In a proof of concept application, specific inhibition of the PI3Kβ isoform in the PTEN-deficient MDA-MB-468 breast cancer cell line confirmed significant alterations in central metabolism while additional changes in pyrimidine biosynthesis and hexosamine pathways were identified.